Title : CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway.

Pub. Date : 2021 Apr 15

PMID : 33764366

1 Functional Relationships(s)
Compound Name
Protein Name
1 In summary, our results showed that nab-paclitaxel increased the expression of CCL26 in CAFs, and CCL26 enhanced the invasive potential of pancreatic cancer cells by activating the PI3K/AKT/mTOR axis. nab AKT serine/threonine kinase 1 Homo sapiens